Worldwide LifeScience Technologies (WLT) is led by Michael J. Andrews, whose knowledge of the life science industry along with an impressive collaboration of life science professionals from around the globe provide the kind of resources clients need to bring medicine to market.
Recent success includes FDA approval of an Investigational New Drug (IND) for a client working on a botanical drug for cancer related fatigue. This client is now relying on WLT to support the next phase of clinical trials.
WLT's primary source of new business is based on referrals from life science professionals who consistently tell prospective investors and prospective clients that Michael's leadership is unparalleled in navigating the FDA approval process with successful outcomes.
Michael J. (Mike) Andrews is Co-Founder of Andrews Performance Corporation (APC) and President of Worldwide LifeScience Technologies (WLT), a division of APC.
WLT consults organizations in the life sciences (biotech, pharma, devices, diagnostics and tools) under the leadership of Michael J. Andrews who holds a number of patents in life science. Mike is known for his passion and precision in bringing success and value to organizations.
Michael served as CEO, President, and Board Member of HyperStem Therapeutics. He was Board Member, President, & CEO of MicroIslet Inc. (MIIS.OB), a cell therapy company.
Mr. Andrews served as Vice-President of Worldwide Operations at Chemicon International Inc., a Serologicals Corporation company. Before then he served as the Senior Director of Manufacturing and Materials at Ancile Pharmaceuticals, Inc., where he was instrumental in the allowance of a number of Investigational New Drug (IND) applications.
He served as Head of Manufacturing and Material Management at NaPro BioTherapeutics, a clinical stage company, in Boulder, Colorado and Victoria, British Columbia. Previous to that, he was Plant Supervisor for Large Scale Fermentation for Synergen Corporation in Boulder, Colorado.
He also served in various manufacturing positions for Genentech, Inc. in South San Francisco, California.